| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.41 | 1e-27 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.29 | 9e-16 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.4 | 1e-13 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-12 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-10 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |